Anne Rigg

Dr Anne Rigg, consultant medical oncologist. Woman with shoulder length blonde hair and glasses.

Consultant medical oncologist and medical director for Cancer and Surgery Clinical Group

Biography

Dr Rigg trained in London and completed her specialist training as a medical oncologist at the Royal Marsden Hospital. She has been a consultant at Guy’s and St Thomas’ Hospitals since 2005. Dr Rigg specialises in the systemic anti-cancer therapies for breast cancer, with an interest in interventional clinical trials and the importance of real world evidence to drive service improvement and generate research hypotheses. 

Dr Rigg is a clinical leader and has held a number of roles within Guy’s and St Thomas’ including clinical director for oncology. She is also currently the medical director for the Cancer and Surgery Clinical Group. She is involved in the development of the clinical leaders of the future. 

She is the NHS England Chair of the Chemotherapy Clinical Reference Group. She represents medical oncology at the Royal College of Physicians Patient Safety Committee and sits on the steering committees of the UK Chemotherapy Board, Association of Physicians and Intercollegiate Committee of Haematology.

Education and training

  • 1989 Intercalated BSc Psychology 

  • 1991 MBBS University of London 

  • 2000 PhD Imperial College 

  • Medical Oncology specialist training, Royal Marsden Hospital, London

Research interests

  • phase 3 clinical trial in breast cancer 
  • real world evidence in cancer 
  • health inequalities for cancer patients

Awards

  • fellowship of the Royal College of Physicians UK

Publications

  • British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer. Marsden et al 2019

  • Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer. Dodson et al Breast Cancer Research 2017

  • The impact of OncotypeDX breast cancer assay results on clinical practice –a UK experienceVE. Crolley et al UKBCG 2016

  • Venous thrombosis rates in early breast cancer patients receiving FEC chemotherapy: a retrospective analysis. ECCO 2011
  • A diagnosis of cancer in people with severe mental illness: practical and ethical issues raised. Howard et al Lancet Oncology 2010.

Last updated: April 2022

Is this page useful?